ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
ONCE
Delisted
ONCE was delisted on the 16th of December, 2019.
160 hedge funds and large institutions have $1.92B invested in Spark Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 61 increasing their positions, 33 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 163 → 160 (-3)
39% less capital invested
Capital invested by funds: $3.15B → $1.92B (-$1.23B)
Holders
160
Holding in Top 10
5
Calls
$33.3M
Puts
$17.5M
Top Buyers
| 1 | +$115M | |
| 2 | +$28.2M | |
| 3 | +$21.1M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$20.1M |
| 5 |
RFS
Rockefeller Financial Services
New York
|
+$18.1M |
Top Sellers
| 1 | -$39.4M | |
| 2 | -$39.3M | |
| 3 | -$38.3M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$34.7M |
| 5 |
Jennison Associates
New York
|
-$27.2M |